Adverse reactions for the use of the monoclonal trastuzumab antibody in the treatment of patients with HER2 positive breast cancer
DOI:
https://doi.org/10.30827/ars.v58i4.6766Keywords:
Antibodies, Monoclonal, Breast Neoplasms, Trastuzumab, Drug-Related Side Effects and Adverse Reactions, Medical OncologyAbstract
Objective: identify the main adverse reactions presented by patients with HER2 positive breast cancer from an outpatient clinic specialized in chemotherapy in the city of Caruaru-PE, after the use of Trastuzumab.
Methods: The data were obtained through the analysis of the medical records of the patients attended at the outpatient clinic from January 2015 to December 2016.
Results: Twenty-four patients were selected, of whom 12.5% presented cardiotoxicity and 4.16% presented abdominal pain, nausea among other adverse events.
Conclusion: Identifying such adverse events makes it possible to better assist the oncological patient and to better adhesion to the treatment. Because they are specific target drugs, few studies are concerned with evaluating these adverse events, which often makes clinical care difficult.
Downloads
References
Bohlandt A, Sverdel Y, Schierl R. Antineoplastic drug residues inside homes of chemotherapy patients. Int J Hyg Environ Health. 2017; 220(4): 757-765.
Meiliana A, Dewi NM, Wijaya A. Cancer Immunotherapy: A Review. Indones Biomed J. 2016; 8(1): 1-20.
Cordeiro MLS, Silva NLFS, Vaz MRF, Nóbrega FFF. Anticorpos monoclonais: implicações terapêuticas no câncer. Rev. Saúde Ciência. 2014; 3(3): 252-262.
Cavalcanti IDL, Santos RJ, Cordeiro RP. Evolução conceitual da biossegurança na manipulação de antineoplásicos. Eletronic Journal of Pharmacy. 2016; 13(1): 6-17.
Yuzhakova DV, Shirmanova MV, Sergeeva TF, Zagaynova EV, Lukyanov KA. Immunotherapy of Cancer (Review). CTM. 2016; 8(1): 173-181.
- Coelho JTA. Anticorpos Monoclonais [tese]. Porto: Universidade Fernando Pessoa; 2014.
Cintra JRD, Teixeira MTB, Diniz RW, Junior HG, Florentino TM, Freitas GF, Oliveira LRM, Neves MTR, Pereira T, Guerra MR. Immunohistochemical profile and clinical-pathological variables in breast cancer. Rev Assoc Med Bras. 2011; 58(2): 178-187.
Santos TP, Paes MA, Ferreira ACSM, Campos T. Avaliação epidemiológica das pacientes com câncer de mama tratadas com trastuzumabe no Hospital de Base de Brasília. Rev Bras Oncol Clin. 2014; 36(10): 55-59.
Matos E, Jug B, Blagus R, Zakotnik B. A Prospective Cohort Study on Cardiotoxicity of Adjuvant Trastuzumab Therapy in Breast Cancer Patients. Arq Bras Cardiol. 2016; 107(1): 40-47.
Ayres LR, Campos MSA, Gozzo TO et al. Trastuzumab induced cardiotoxicity in HER2 positive breast cancer patients attended in a tertiary hospital. Int J Clin Pharm. 2015; 37: 365-372.
Costa MP, Castier MB, Salgado CG. Papel do Ecocardiograma na Avaliação da Cardiotoxicidade no Tratamento do Câncer de Mama. Rev Bras Cardiol. 2011; 24(6): 382-386.
Albini A, Pennesi G, Donatelli F, Cammarota R, Flora S, Noonan DM. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardiooncological prevention. J Natl Cancer Inst. 2009; 102(1): 14-25.
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
